Late last year we introduced the Fat’hieh Canine BRAF mutation PCR test, and we’ve seen strong interest from veterinarians across New Zealand.
Based on the questions coming through, we’re keen to share more detail on how this test can be used in practice and to address common clinical questions around interpretation and case selection.
We invite you to join us for a live webinar on canine transitional cell carcinoma/urothelial cell carcinoma (TCC/UC), and the clinical application of canine BRAF testing.
The BRAF mutation occurs in around 85% of dogs with TCC/UC, offering a powerful tool for early detection and helping guide further diagnostic and treatment decisions. The Fat’hieh BRAF mutation PCR is a non-invasive test performed on a free-catch urine sample. Previously, this testing required referral overseas; it is now developed, validated and performed locally in New Zealand.
Webinar details
Date: Wednesday 25 February 2026
Time: 12.00 – 1.00 pm
Presenter: Dr Kathryn Jenkins, Clinical Pathologist, Awanui Veterinary
There will be a 45-minute presentation, followed by 15 minutes for live Q&A.
Register here to confirm your spot
What we’ll cover
> What is the canine Fat’hieh BRAF mutation PCR test?
> Overview of canine TCC/UC
> Using BRAF testing in cases with suspected TCC/UC
> Use of BRAF testing as a screening tool in high-risk dogs
> Interpretation of results
> How BRAF testing fits alongside other diagnostic modalities
> Practical guidance on sample collection and submission
The webinar will be recorded and made available for on-demand viewing after the event to all registered attendees. So even if you can’t attend, make sure you register!
Secure your seat for the webinar now
